| Product NDC: | 54505-102 |
| Proprietary Name: | epinephrine |
| Non Proprietary Name: | epinephrine |
| Active Ingredient(s): | .3 mg/.3mL & nbsp; epinephrine |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 54505-102 |
| Labeler Name: | Lineage Therapeutics Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020800 |
| Marketing Category: | NDA AUTHORIZED GENERIC |
| Start Marketing Date: | 20100401 |
| Package NDC: | 54505-102-02 |
| Package Description: | 2 CASE in 1 CARTON (54505-102-02) > 1 SYRINGE, GLASS in 1 CASE > .3 mL in 1 SYRINGE, GLASS |
| NDC Code | 54505-102-02 |
| Proprietary Name | epinephrine |
| Package Description | 2 CASE in 1 CARTON (54505-102-02) > 1 SYRINGE, GLASS in 1 CASE > .3 mL in 1 SYRINGE, GLASS |
| Product NDC | 54505-102 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | epinephrine |
| Dosage Form Name | INJECTION |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20100401 |
| Marketing Category Name | NDA AUTHORIZED GENERIC |
| Labeler Name | Lineage Therapeutics Inc. |
| Substance Name | EPINEPHRINE |
| Strength Number | .3 |
| Strength Unit | mg/.3mL |
| Pharmaceutical Classes | Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [Chemical/Ingredient] |